Affordable Access

Dermatan sulfate inhibits osteoclast formation by binding to receptor activator of NF-kappa B ligand.

Authors
Type
Published Article
Journal
Biochemical and Biophysical Research Communications
0006-291X
Publication Date
Volume
354
Issue
2
Pages
447–452
Identifiers
PMID: 17239341
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments